Schedule 13D ownership disclosure

APREA THERAPEUTICS INC

Security class unavailable · CUSIP: 03836J102

Event date: 2021-02-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
594,392
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-024363
Form type
SC 13D
Filer
5AM Ventures IV, L.P.
CIK
CIK 1589315
Filed
Feb 16, 2021
Reporting period
Feb 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub